KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to $56.7 million.

  • Emergent BioSolutions' Shares Outstanding (Diluted Average) rose 197.84% to $56.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.7 million, marking a year-over-year increase of 197.84%. This contributed to the annual value of $53.0 million for FY2024, which is 351.56% up from last year.
  • As of Q3 2025, Emergent BioSolutions' Shares Outstanding (Diluted Average) stood at $56.7 million, which was up 197.84% from $56.7 million recorded in Q2 2025.
  • Emergent BioSolutions' Shares Outstanding (Diluted Average)'s 5-year high stood at $57.3 million during Q1 2025, with a 5-year trough of $50.1 million in Q4 2022.
  • In the last 5 years, Emergent BioSolutions' Shares Outstanding (Diluted Average) had a median value of $52.6 million in 2024 and averaged $53.0 million.
  • Per our database at Business Quant, Emergent BioSolutions' Shares Outstanding (Diluted Average) tumbled by 755.06% in 2022 and then surged by 977.01% in 2025.
  • Quarter analysis of 5 years shows Emergent BioSolutions' Shares Outstanding (Diluted Average) stood at $54.1 million in 2021, then decreased by 7.39% to $50.1 million in 2022, then grew by 2.2% to $51.2 million in 2023, then grew by 3.52% to $53.0 million in 2024, then increased by 6.98% to $56.7 million in 2025.
  • Its last three reported values are $56.7 million in Q3 2025, $56.7 million for Q2 2025, and $57.3 million during Q1 2025.